Atogepant: Mechanism of action, clinical and translational science

Documenti analoghi

• Ubrogepant: Mechanism of action, clinical and translational science
  di: Ramesh Boinpally, et al.
  Pubblicazione: (2024)
• Cerebrospinal Fluid and Plasma Concentrations of Atogepant in Humans
  di: Ramesh R. Boinpally, et al.
  Pubblicazione: (2026)
• Ubrogepant Plasma and Cerebrospinal Fluid Exposures in Participants With a History of Migraine: Findings From a Phase 1b Open‐Label Trial
  di: Ramesh R. Boinpally, et al.
  Pubblicazione: (2026)
• Mass Balance and Metabolism of 14 C ‐Atogepant in Healthy Male Participants: Findings of a Phase 1 Clinical Trial
  di: Ramesh R. Boinpally, et al.
  Pubblicazione: (2025)
• Molnupiravir: Mechanism of action, clinical, and translational science
  di: Brian M. Maas, et al.
  Pubblicazione: (2024)